How Lasa Health is Transforming Women’s Health

AI Health Coach for Pelvic Pain and Endometriosis

Endometriosis Affects 1 in 10 women

Endometriosis is a painful, chronic condition that affects 1 in 10 women. It can be devastating physically, emotionally, and financially for patients, and yet 63% of medical providers report being uncomfortable treating it, and it can take anywhere from 5 to 12 years to diagnose.

Women with endometriosis are significantly more likely to work outside of their desired profession because of physical limitations. They are faced with challenges in generating consistent income thanks to interruptions from symptoms and often need to pay high out-of-pocket medical expenses. These medical costs and the loss of productivity associated with endometriosis result in an annual $69 billion economic burden, just within the US. 

Lasa’s Solution

Patient and provider education is extremely important in reducing the time women have to wait before receiving a diagnosis, and ultimately driving down the societal and economic burden of this disease. Lasa Health helps patients decrease the time to diagnosis by leveraging large language model artificial intelligence, LLM AI. 

Prior to speaking with a provider, patients can use Lasa’s proprietary Pelvic Pain Assessment. Lasa Health uses LLM AI to help patients narrow down the source of their pelvic pain and highlight symptoms to bring up with their medical providers. Providers are supported as well, with Lasa Health’s large data set helping to connect the sometimes random-seeming dots between endometriosis signs and symptoms. 

Endometriosis can be highly debilitating, depending on its severity. In addition to the pain and financial strain placed on women, it is one of the leading causes of fertility, impacting couples globally. Supporting the 1 in 10 women struggling with endometriosis also supports hopeful parents, families, and everyone in the workplace.

For more information about Lasa Health, visit and follow them on LinkedIn

For more information on Femovate visit and follow us on LinkedIn

For interviews please contact Theresa Neil

Stay in touch

The application period for Femovate 2023-24 is now closed. Follow us on LinkedIn for updates and the selected startups announcement.